T5	Subject 9 21	Two patients
T7	Treatment 104 141;212 224	intravitreal injection of bevacizumab 2 days later
T9	Effect 185 211	infectious endophthalmitis
T10	Population 9 12	Two
T11	Treat-Disorder 27 69	exudative age-related macular degeneration
T6	Route 104 126	intravitreal injection
T12	Drug 130 141	bevacizumab
T13	Time_elapsed 212 225	2 days later.
T14	Severity_cue 165 171	severe
T8	Adverse_event 146 155	developed
E1	Adverse_event:T8 
A1	Severity E1 High